# Carbetocin vs. Oxytocin at Elective Cesarean Section

> **NCT03168698** · NA · COMPLETED · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 278 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Carbetocin
- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT03168698
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-25
- **Primary completion:** 2020-12-17
- **Final completion:** 2020-12-18
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03168698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03168698, "Carbetocin vs. Oxytocin at Elective Cesarean Section". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03168698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*